Market Overview

UPDATE: Oppenheimer Upgrades UnitedHealth Group to Outperform; Valuation is Overly Pessimistic

Share:
Related UNH
Jim Cramer Weighs In On Nucor, CIGNA, Advanced Micro Devices And Viacom
Jim Cramer Gives His Opinion On Tesla, Pfizer And UnitedHealth
US Market Indexes Start the Week Higher (GuruFocus)

Oppenheimer upgraded UnitedHealth Group (NYSE: UNH) from Perform to Outperform and raises the price target from $63.00 to $66.00.

Oppenheimer commented, "We believe that UNH's current discounted multiples appear attractive in light of the overly-pessimistic outlook regarding the impact of the ACA, and the recent pull-back related to MA rates. Furthermore, following the Q4:12 earnings conference call, we have increased confidence that FY2013 results will outperform expectations. With strong cash flow, a well-diversified portfolio and a strong track record of performance, we would be buyers of UNH."

UnitedHealth Group closed at $55.21 on Wednesday.

Latest Ratings for UNH

DateFirmActionFromTo
Apr 2017Deutsche BankInitiates Coverage OnBuy
Feb 2017Cantor FitzgeraldInitiates Coverage OnOverweight
Jan 2017PiperJaffrayInitiates Coverage OnOverweight

View More Analyst Ratings for UNH
View the Latest Analyst Ratings

Posted-In: OppenheimerAnalyst Color Upgrades Analyst Ratings

 

Related Articles (UNH)

View Comments and Join the Discussion!